Biosimilars Conference 2015
Date: | 04-Nov-15 to 05-Nov-15 |
Location: | De Vere Venues / London / United Kingdom |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
This 2-day conference is the third of its kind. It will provide an update on the current status for biosimilars in EU and internationally with focus on both regulatory and scientific challenges as well as market access and experiences. Patients and physicians approach to use of biosimilars will be part of the conference scope including a discussion on biosimilars adoption into current treatment guidelines in EU. The conference will consist of plenary lectures followed by interactive panel discussions providing participants an opportunity to bring forward their own experience and share their thoughts and ideas with the experts.
Featured Topics
Current regulatory status of biosimilars in the EU
International development of biosimilars
Naming of biologicals including biosimilars
Pharmacovigilance issues related to biosimilars – EU and globally
Market experience with biosimilars including market access and pricing
Patient and physicians approach to use of biosimilars
This conference is aimed at intermediate and experienced professionals from:
Regulatory agencies
The pharmaceutical industry and service providers including
Regulatory affairs personnel
Pharmacovigilance staff
Clinical and medical personnel
Academic institutions
Physicians and their scientific societies
Patients organisations
Learning Objectives
Deal with regulatory requirements, scientific and operational challenges
Exchange experiences and discuss Hot Topics with experts
Update the participant on the current knowledge including regulatory and scientific thinking
Discuss pros and cons of Biosimilars
Featured Topics
Current regulatory status of biosimilars in the EU
International development of biosimilars
Naming of biologicals including biosimilars
Pharmacovigilance issues related to biosimilars – EU and globally
Market experience with biosimilars including market access and pricing
Patient and physicians approach to use of biosimilars
This conference is aimed at intermediate and experienced professionals from:
Regulatory agencies
The pharmaceutical industry and service providers including
Regulatory affairs personnel
Pharmacovigilance staff
Clinical and medical personnel
Academic institutions
Physicians and their scientific societies
Patients organisations
Learning Objectives
Deal with regulatory requirements, scientific and operational challenges
Exchange experiences and discuss Hot Topics with experts
Update the participant on the current knowledge including regulatory and scientific thinking
Discuss pros and cons of Biosimilars
Exhibitors
Christian Schneider, Steffen Thirstrup, Sabine Atzor
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today